- Home
- HOUS vs IGMS Comparison
HOUS vs IGMS Comparison
Compare HOUS & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUS
- IGMS
- Stock Information
- Founded
- HOUS 2006
- IGMS 1993
- Country
- HOUS United States
- IGMS United States
- Employees
- HOUS N/A
- IGMS N/A
- Industry
- HOUS Real Estate
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- HOUS Finance
- IGMS Health Care
- Exchange
- HOUS Nasdaq
- IGMS Nasdaq
- Market Cap
- HOUS 445.0M
- IGMS 528.6M
- IPO Year
- HOUS 2006
- IGMS 2019
- Fundamental
- Price
- HOUS $4.93
- IGMS $10.55
- Analyst Decision
- HOUS Sell
- IGMS Buy
- Analyst Count
- HOUS 4
- IGMS 7
- Target Price
- HOUS $5.88
- IGMS $15.57
- AVG Volume (30 Days)
- HOUS 1.1M
- IGMS 269.3K
- Earning Date
- HOUS 11-07-2024
- IGMS 11-08-2024
- Dividend Yield
- HOUS N/A
- IGMS N/A
- EPS Growth
- HOUS N/A
- IGMS N/A
- EPS
- HOUS N/A
- IGMS N/A
- Revenue
- HOUS $5,580,000,000.00
- IGMS $2,918,000.00
- Revenue This Year
- HOUS $3.18
- IGMS $386.95
- Revenue Next Year
- HOUS $7.74
- IGMS N/A
- P/E Ratio
- HOUS N/A
- IGMS N/A
- Revenue Growth
- HOUS N/A
- IGMS 57.64
- 52 Week Low
- HOUS $3.01
- IGMS $5.58
- 52 Week High
- HOUS $8.40
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- HOUS 64.16
- IGMS 42.69
- Support Level
- HOUS $4.76
- IGMS $9.05
- Resistance Level
- HOUS $4.21
- IGMS $10.15
- Average True Range (ATR)
- HOUS 0.25
- IGMS 1.04
- MACD
- HOUS 0.11
- IGMS 0.17
- Stochastic Oscillator
- HOUS 77.46
- IGMS 56.84
About HOUS Anywhere Real Estate Inc.
Anywhere Real Estate Inc operates in residential real estate, focusing on brokerage, relocation, title, settlement businesses, and mortgage and title insurance ventures. It supports approximately 1 million home sale sides annually. Brands include Better Homes and Gardens, CENTURY 21, Coldwell Banker, Corcoran, ERA, and Sotheby's International Realty. Revenue comes mainly from existing home transactions. Operations are segmented into Anywhere Brands (franchises), Anywhere Advisors (owned brokerage), and Anywhere Integrated Services (title and settlement).
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.